Qureshi, Adnan I.
Huang, Wei https://orcid.org/0000-0001-9683-7590
Hanley, Daniel F.
Hsu, Chung Y.
Martin, Renee H.
Malhotra, Kunal
Steiner, Thorsten
Suarez, Jose I.
Yamamoto, Haruko
Toyoda, Kazunori
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U01NS062091)
National Institute of Neurological Disorders and Stroke (U01NS062091)
National Cerebral and Cardiovascular Center (H23-4-3)
Article History
Received: 8 December 2021
Accepted: 5 April 2022
First Online: 5 May 2022
Conflict of interest
: Dr. Qureshi has received a grant from the National Institute of Neurological Disorders and Stroke (U01NS062091) and consultation fees from AstraZeneca. Ms. Huang has nothing to disclose. Dr. Hanley has received a grant from the National Institute of Neurological Disorders and Stroke (U01NS062091) and personal fees from Neurotrope, outside the submitted work. Dr. Hsu has nothing to disclose. Dr. Martin has nothing to disclose. Dr. Malhotra has nothing to disclose. Dr. Steiner has reported personal fees from Daiichi-Sankyo, Bayer, Bristol-Myers-Squibb, Boehringer, and Alexion, outside the submitted work. Dr. Suarez has nothing to disclose. Dr. Yamamoto has nothing to disclose. Dr. Toyoda has received a grant from the Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center (H23-4–3).
: Adherence to ethical guidelines and indicate ethical approvals (institutional review board) and use of informed consent, as appropriate.